|
|
|
|
Direct Cost |
Indirect Cost |
|
1K01MH115785-01A1 |
Developing Tailored Delivery and Adherence Interventions for use of Long-Acting Biomedical HIV Prevention Strategies by Transgender Women |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$169,270 |
$13,542 |
$182,812 |
1K01MH118428-01 |
Neural Correlates of Location-Specific Contextual Threat Discrimination in Post-Traumatic Stress Disorders |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$169,700 |
$13,576 |
$183,276 |
1K08MH115365-01A1 |
Neural mechanisms for the genesis of conceptual information |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$185,000 |
$14,800 |
$199,800 |
1K08MH116368-01 |
Mapping Serotonergic Activity During Emotional Behaviors in the Healthy and Stressed Brain |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$184,969 |
$14,798 |
$199,767 |
1K23DA045080-01A1 |
A Randomized Controlled Trial of Lorcaserin for the Treatment of Cannabis Use Diosrder |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIDA |
$182,334 |
$14,587 |
$196,921 |
1K23MH114021-01A1 |
Predicting complicated grief from grief processing |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$184,997 |
$14,800 |
$199,797 |
1K99HG010084-01 |
Understanding Implications of Genetic Attributions for Addiction |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NHGRI |
$155,024 |
$11,622 |
$166,646 |
1P50MH115843-01 |
OPTIMIZING AND PERSONALIZING INTERVENTIONS FOR SCHIZOPHRENIA ACROSS THE LIFESPAN (OPAL) |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$1,447,877 |
$652,537 |
$2,100,414 |
1R01AA025947-01A1 |
Community I-STAR Mozambique: Community Implementation of SBIRT using Technology for Alcohol use Reduction in Mozambique |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIAAA |
$529,365 |
$175,118 |
$704,483 |
1R01AG051346-01A1 |
Novel Cognitive and Functional Measure for Alzheimers Disease Prevention Trials |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIA |
$1,362,924 |
$232,871 |
$1,595,795 |
1R01EB026481-01 |
Noninvasive Quantification of Brain Glucose Metabolism Using a Portable Positron Emission Tomography Camera. |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIBIB |
$315,952 |
$133,695 |
$449,647 |
1R01ES027424-01A1 |
Prenatal endocrine-disrupting chemicals and social/cognitive risk in mothers and infants: Potential biologic pathways |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIEHS |
$477,398 |
$139,415 |
$616,813 |
1R01HD095256-01 |
Improving Assessment for Neurocognitive Impairment among Perinatally HIV Infected Youth |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NICHD |
$473,423 |
$132,713 |
$606,136 |
1R01MH114965-01A1 |
Deficient Belief Updating as a Convergent Computational Mechanism of Psychosis |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$496,251 |
$294,045 |
$790,296 |
1R01MH114967-01A1 |
A multi-cohort assessment of gestational SSRI exposure on long-term psychiatric outcomes |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$649,278 |
$113,061 |
$762,339 |
1R01MH115024-01A1 |
1/2 Task control circuit targets for obsessive compulsive behaviors in children |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$247,827 |
$123,101 |
$370,928 |
1R01MH117128-01 |
Targeting cotransmission for circuit-specific pharmacotherapy |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$421,402 |
$177,784 |
$599,186 |
1R01MH117323-01 |
Individualized risk prediction in persons at clinical high-risk for psychosis using neuromelanin-sensitive MRI. |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIMH |
$477,017 |
$263,168 |
$740,185 |
1R21AA026049-01A1 |
Effect of rTMS to the Prefrontal Cortex in Alcohol Use Disorders |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIAAA |
$118,750 |
$73,625 |
$192,375 |
1R21AG059130-01 |
Sensation and Psychiatry: Linking Age-Related Hearing Loss toLate-Life Depression and Cognitive Decline |
NEW YORK STATE PSYCHIATRIC INSTITUTE |
NIA |
$160,867 |
$55,937 |
$216,804 |